Major depressive disorder: An organic disorder!
Yrondi A, Sporer M, Schmitt L, Arbus C.
Presse Med. 2018 Feb;47(2):113-115. doi: 10.1016/j.lpm.2017.12.005.
Pseudo-melancholia.
Parker G.
Australas Psychiatry. 2020 Jun;28(3):339-341. doi: 10.1177/1039856220908167. Epub 2020 Mar 11.
Vortioxetine's cardiovascular profile as a relevant feature for the management of major depressive disorder in comorbidity with organic diseases.
Dell'osso B, Blasi G, Serafini G, Serrati C, Bianchetti A, Porto I, Forleo GB, Pugliese A, Mastrostefano A, Nicoletti F.
Expert Rev Neurother. 2026 Feb;26(2):175-184. doi: 10.1080/14737175.2025.2602193. Epub 2025 Dec 29.
Treatment-resistant depression.
Souery D, Papakostas GI, Trivedi MH.
J Clin Psychiatry. 2006;67 Suppl 6:16-22.
Gut-brain axis volatile organic compounds derived from breath distinguish between schizophrenia and major depressive disorder.
Henning D, Lüno M, Jiang C, Meyer-Lotz G, Hoeschen C, Frodl T.
J Psychiatry Neurosci. 2023 Apr 12;48(2):E117-E125. doi: 10.1503/jpn.220139. Print 2023 Mar-Apr.
Bright light therapy.
Prasko J.
Neuro Endocrinol Lett. 2008 Nov;29 Suppl 1:33-64.
[Psychosomatic and organic etiology of depressive disorder].
Omori T.
Seishin Shinkeigaku Zasshi. 2007;109(9):844-5.
Long-lasting dissociative amnesia.
Nilsson E, Sørensen MR.
Ugeskr Laeger. 2024 Feb 26;186(9):V08230513. doi: 10.61409/V08230513.
Overview: pseudodementia.
McAllister TW.
Am J Psychiatry. 1983 May;140(5):528-33. doi: 10.1176/ajp.140.5.528.
[The role of premorbid personality in the genesis of psychopathological symptomatology in patients with organic anxiety-depressive disorder, schizophrenia and endogenous depression].
Kalinin VV, Syrtsev MA, Zemlyanaya AA, Fedorenko EA, Sokolova LV.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(7):94-99. doi: 10.17116/jnevro202212207194.
